Hörkkö Sohvi

 

Humoral Immunity and Atherosclerosis

 

Research unit: Biomedicine

 

Group leader

Professor Sohvi Hörkkö (MD, PhD, eMBA)

 

What do we do

Atherosclerotic cardiovascular diseases remain a major cause of death and disability worldwide. Atherosclerosis is a chronic inflammatory disease of the vessel wall characterized by increased oxidative stress. One of the candidate sets of antigens for immune system in atherosclerosis is oxidized lipid epitopes. Our research group investigates the role of natural and adaptive humoral immune responses to oxidized lipid epitopes in the development of atherosclerosis. We are focused in cloning and characterizing antibodies to epitopes that share molecular mimicry with microbial pathogens.

 

Our team

Post doc researchers

  • Harila Kirsi, PhD
  • Nissinen Antti, PhD
  • Wang Chunguang, MD, PhD

PhD students

  • Kankaanpää Jari, MD
  • Kummu Outi, MSc
  • Kyrklund Dan Mikael, MSc (Technology), Medical student
  • Mattila Riikka, MSc
  • Partanen Samu, Medical student
  • Raumonen Salli, Medical student
  • Sahavirta Simo, Medical student
  • Sahlman Marjo, Medical student
  • Turunen Pauliina, MSc
  • Vehkala Lauri, Medical student

Other staff

  • Rannikko Sirpa, Biomedical laboratory scientist

 

Where are we headed

The chronic inflammatory processes throughout the life are modulated by the innate and adaptive immune system. We aim discover the roles of gut microbiota and mucosal immune system in the pathogenesis of atherosclerosis. Our research group aims to identify novel target therapies modulating the immune system to alter the course of atherogenesis.

 

How to find us

sohvi.horkko[at]oulu.fi

Last updated: 9.7.2019